SCHEMBL5193372

SCHEMBL5193372

COc1ccc(C(=O)NC(C(=O)O)C(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.59
TAS1R1 Q7RTX1 1/20 0.59
CA1 P00915 4/20 0.59
CA2 P00918 4/20 0.59
PLK1 P53350 1/20 0.59
ALDH1A1 P00352 6/20 0.56
CYP3A4 P08684 2/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
TP53 P04637 2/20 0.56
ALOX15 P16050 1/20 0.56
GAA P10253 3/20 0.55
CRHBP P24387 1/20 0.55
CRHR2 Q13324 1/20 0.55
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 1/20 0.54
HTT P42858 1/20 0.54
F10 P00742 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13771219 0.92 TAS1R3 (0.55) TAS1R3TAS1R1CA1CA2PLK1
SCHEMBL10980522 0.86 TAS1R3 (0.59) TAS1R3TAS1R1CA1CA2PLK1
SCHEMBL5637591 0.84 CA2 (0.58) TAS1R3TAS1R1CA1CA2PLK1
SCHEMBL9829827 0.84 CA2 (0.58) TAS1R3TAS1R1CA1CA2PLK1
SCHEMBL8330051 0.83 CA1 (0.66) TAS1R3TAS1R1CA1CA2PLK1
SCHEMBL7410707 0.81 NPSR1 (0.71) TAS1R3TAS1R1CA1CA2PLK1
SCHEMBL5838728 0.81 NPSR1 (0.71) TAS1R3TAS1R1CA1CA2PLK1
SCHEMBL9828979 0.80 NPSR1 (0.57) TAS1R3TAS1R1CA1CA2PLK1
SCHEMBL5424180 0.80 TAS1R3 (0.61) TAS1R3TAS1R1CA1CA2PLK1
SCHEMBL9829566 0.80 CA2 (0.63) TAS1R3TAS1R1CA1CA2PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812383-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF Smithkline Beecham Corporation (US) 2007-08-01 EP disclosed
WO-2006052722-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF SMITHKLINE BEECHAM CORPORATION (US) 2006-05-18 WO disclosed